These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748 [TBL] [Abstract][Full Text] [Related]
4. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Charlton A; Blair V; Shaw D; Parry S; Guilford P; Martin IG Gut; 2004 Jun; 53(6):814-20. PubMed ID: 15138207 [TBL] [Abstract][Full Text] [Related]
5. E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. Humar B; Blair V; Charlton A; More H; Martin I; Guilford P Cancer Res; 2009 Mar; 69(5):2050-6. PubMed ID: 19223545 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075 [TBL] [Abstract][Full Text] [Related]
7. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer]. de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213 [TBL] [Abstract][Full Text] [Related]
8. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658 [TBL] [Abstract][Full Text] [Related]
9. Synchronous appendiceal and intramucosal gastric signet ring cell carcinomas in an individual with CDH1-associated hereditary diffuse gastric carcinoma: a case report of a novel association and review of the literature. Hamilton LE; Jones K; Church N; Medlicott S BMC Gastroenterol; 2013 Jul; 13():114. PubMed ID: 23849133 [TBL] [Abstract][Full Text] [Related]
10. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. Carneiro F; Huntsman DG; Smyrk TC; Owen DA; Seruca R; Pharoah P; Caldas C; Sobrinho-Simões M J Pathol; 2004 Jun; 203(2):681-7. PubMed ID: 15141383 [TBL] [Abstract][Full Text] [Related]
11. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer. Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759 [TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer. Funakoshi T; Miyamoto S; Kakiuchi N; Nikaido M; Setoyama T; Yokoyama A; Horimatsu T; Yamada A; Torishima M; Kosugi S; Yamada H; Sugimura H; Haga H; Sakai Y; Ogawa S; Seno H; Muto M; Chiba T Gastric Cancer; 2019 Jul; 22(4):892-898. PubMed ID: 30542785 [TBL] [Abstract][Full Text] [Related]
14. Hereditary Diffuse Gastric Cancer Treated by Prophylactic Total Gastrectomy. Inaba Y; Goda K; Kondo M; Abe K; Kanamori A; Suzuki T; Tominaga K; Nakagawa M; Morita S; Kojima K; Ishida K; Irisawa A Intern Med; 2024 Jan; 63(2):235-239. PubMed ID: 37225495 [TBL] [Abstract][Full Text] [Related]
15. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk. Gamble LA; Rossi A; Fasaye GA; Kesserwan C; Hernandez JM; Blakely AM; Davis JL JAMA Surg; 2022 Jan; 157(1):18-22. PubMed ID: 34643667 [TBL] [Abstract][Full Text] [Related]
16. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status. Mi EZ; Mi EZ; di Pietro M; O'Donovan M; Hardwick RH; Richardson S; Ziauddeen H; Fletcher PC; Caldas C; Tischkowitz M; Ragunath K; Fitzgerald RC Gastrointest Endosc; 2018 Feb; 87(2):408-418. PubMed ID: 28688938 [TBL] [Abstract][Full Text] [Related]
17. Histologic and immunohistochemical differences between hereditary and sporadic diffuse gastric carcinoma. Lee HE; Smyrk TC; Zhang L Hum Pathol; 2018 Apr; 74():64-72. PubMed ID: 29307626 [TBL] [Abstract][Full Text] [Related]
18. A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach. Caggiari L; Miolo G; Canzonieri V; De Zorzi M; Alessandrini L; Corona G; Cannizzaro R; Santeufemia DA; Cossu A; Buonadonna A; De Re V Cancer Biol Ther; 2018 Apr; 19(4):254-259. PubMed ID: 29131691 [TBL] [Abstract][Full Text] [Related]
19. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512 [TBL] [Abstract][Full Text] [Related]
20. Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study. Lee CYC; Olivier A; Honing J; Lydon AM; Richardson S; O'Donovan M; Tischkowitz M; Fitzgerald RC; di Pietro M Lancet Oncol; 2023 Jan; 24(1):107-116. PubMed ID: 36509094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]